Search

everythinglearnresearchcommunity

for

Search:↓

Higher enzyme levels found in women with hair loss, suggesting hormone imbalance.

Androgens can cause hair growth in some areas but hair loss on the scalp.

Medicines that lower androgen levels and hair removal treatments help manage excessive hair and acne in women with PCOS.

Increased FGFR2b signaling, influenced by androgens, plays a role in causing acne.

Spironolactone is safe for treating female hair loss, but the safety of other drugs is uncertain.

Understanding how DHT works is important for diagnosing and treating hormone-related disorders.

Long-term use of finasteride and dutasteride can cause serious health issues like diabetes and liver problems.

Bioengineering can potentially treat hair loss by regenerating hair follicles and cloning hair, but the process is complex and needs more research.

Hormones like testosterone and estrogen significantly affect hair growth and structure.

Balding hair follicle cells are smaller, grow less well, and need more effort to culture than non-balding cells.

Hair loss in women may have multiple causes, and eyebrow regrowth possible with specific injections.

Hormonal therapy is a treatment option for acne, the only medical treatment for hirsutism, and the most promising for androgenetic alopecia.

Minoxidil and finasteride can slow or halt hair loss, but may have side effects.

The main enzyme found in pubic skin that could be targeted to treat excessive hair growth is 5 alpha-R2.

Finasteride effectively treats hair loss and enlarged prostate in men, with mild side effects.

Finasteride treats enlarged prostate and may help with baldness, but effects on sexual function and male fetuses are unclear.

Male pattern baldness involves genetics, hormones, and needs better treatments.

The model suggests that scalp tension could lead to hair loss, with factors like blood vessel hardening, enlarged oil glands, and poor microcirculation also playing a role. It also hints at a possible link between skull shape and baldness pattern.

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.

FPHL causes hair loss in women due to genetics and hormones; minoxidil and anti-androgens are treatments, and early intervention is advised.

Amenorrhea, or the absence of periods, should be evaluated by age 15 or within five years of early breast development, and is most commonly caused by conditions like polycystic ovary syndrome and hypothalamic amenorrhea.

In Japan, sex reassignment surgery for gender identity disorder faces challenges and needs better medical support and education.

Over 50% of women over 50 experience hair loss, with minoxidil being the only proven effective treatment.

Finasteride shows promise for treating hair loss and excessive hair growth, but more research is needed to confirm its effectiveness and safety.

Women with acne have lower levels of a specific hormone marker than women without acne.

Finasteride lowers DHT levels and raises testosterone in a dose-dependent way.

The document concludes that accurate diagnosis of male and female gonadal disorders is crucial for effective treatment and better patient outcomes.

Finasteride may effectively treat hair loss in Klinefelter Syndrome patients.

Early diagnosis and treatment, using finasteride, minoxidil, or hair transplantation, improves hair loss outcomes.

Eating less sugar, milk, and saturated fats and more vegetables and fish may help treat and prevent acne.